FI69843C - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara isoxazolylindolaminer - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt anvaendbara isoxazolylindolaminer Download PDF

Info

Publication number
FI69843C
FI69843C FI811101A FI811101A FI69843C FI 69843 C FI69843 C FI 69843C FI 811101 A FI811101 A FI 811101A FI 811101 A FI811101 A FI 811101A FI 69843 C FI69843 C FI 69843C
Authority
FI
Finland
Prior art keywords
formula
compound
ethyl
isoxazolyl
methyl
Prior art date
Application number
FI811101A
Other languages
English (en)
Finnish (fi)
Other versions
FI69843B (fi
FI811101L (fi
Inventor
Leonard Jay Brand
Jeffrey Nadelson
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI811101L publication Critical patent/FI811101L/fi
Application granted granted Critical
Publication of FI69843B publication Critical patent/FI69843B/fi
Publication of FI69843C publication Critical patent/FI69843C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI811101A 1980-04-10 1981-04-09 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara isoxazolylindolaminer FI69843C (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US13887280A 1980-04-10 1980-04-10
US13887380A 1980-04-10 1980-04-10
US13887380 1980-04-10
US13887280 1980-04-10
US19678580A 1980-10-14 1980-10-14
US19678580 1980-10-14

Publications (3)

Publication Number Publication Date
FI811101L FI811101L (fi) 1981-10-11
FI69843B FI69843B (fi) 1985-12-31
FI69843C true FI69843C (fi) 1986-05-26

Family

ID=27385244

Family Applications (1)

Application Number Title Priority Date Filing Date
FI811101A FI69843C (fi) 1980-04-10 1981-04-09 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara isoxazolylindolaminer

Country Status (11)

Country Link
EP (2) EP0083566A1 (xx)
AU (1) AU546620B2 (xx)
CA (1) CA1163267A (xx)
DE (1) DE3164982D1 (xx)
DK (1) DK153881A (xx)
ES (1) ES8300757A1 (xx)
FI (1) FI69843C (xx)
IL (1) IL62605A (xx)
MY (1) MY8500913A (xx)
NZ (1) NZ196762A (xx)
PT (1) PT72817B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0084292B1 (en) * 1981-12-14 1985-02-13 Sandoz Ag N,n-disubstituted alkenamides and phenylalkenamides, processes for their production and their use as pharmaceuticals
CH656124A5 (de) * 1982-04-13 1986-06-13 Sandoz Ag 2-substituierte-3-indolamine, verfahren zu deren herstellung sowie deren verwendung.
NZ227841A (en) * 1988-02-12 1991-08-27 Merck Sharp & Dohme Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions
GB8808433D0 (en) * 1988-04-11 1988-05-11 Merck Sharp & Dohme Therapeutic agents
ATE204275T1 (de) * 1990-06-07 2001-09-15 Astrazeneca Ab Indolderivate als 5-ht1-like agonisten

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1075156A (en) * 1963-08-27 1967-07-12 Luso Farmaco Inst Substituted piperazines
US3467670A (en) * 1964-10-05 1969-09-16 Mcneilab Inc 2-phenyl-3-amido-5,6-dimethoxyindoles
US4059583A (en) * 1975-11-13 1977-11-22 Mcneil Laboratories, Incorporated Substituted indoles

Also Published As

Publication number Publication date
DK153881A (da) 1981-10-11
PT72817B (en) 1982-07-26
CA1163267A (en) 1984-03-06
EP0038298B1 (en) 1984-07-25
PT72817A (en) 1981-05-01
AU546620B2 (en) 1985-09-12
IL62605A (en) 1984-10-31
MY8500913A (en) 1985-12-31
AU6930181A (en) 1981-10-15
ES501220A0 (es) 1982-11-01
FI69843B (fi) 1985-12-31
IL62605A0 (en) 1981-06-29
ES8300757A1 (es) 1982-11-01
EP0083566A1 (en) 1983-07-13
FI811101L (fi) 1981-10-11
NZ196762A (en) 1984-07-06
EP0038298A1 (en) 1981-10-21
DE3164982D1 (de) 1984-08-30

Similar Documents

Publication Publication Date Title
US3238215A (en) 1-[(3-, 2-, and 1-indolyl)-lower-alkyl-, lower-alkenyl-, and lower-alkynyl]piperidines
US4954502A (en) 1-indolyalkyl-4-(substituted-pyridinyl)piperazines
US4059621A (en) Substituted benzamido propanolamines
JPS59507B2 (ja) 新規な複素環式化合物の製造方法
JPH0684370B2 (ja) ムスカリンレセプター拮抗薬
US4999355A (en) Isoindolinone derivatives, processes for preparing them and medicines containing them
EP0677042B1 (fr) Ligands selectifs des recepteurs 5ht1d-5ht1b derives d'indole-piperazine utiles comme medicaments
US3699123A (en) 4-(3-amino-2-hydroxy-propoxy) indole derivatives
FR2574793A1 (fr) Composes derives d'indole, compositions pharmaceutiques les contenant et procede pour leur preparation
FI69843B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara isoxazolylindolaminer
IE42978B1 (en) Triaryl alkyl azabicyclo compounds
US4902687A (en) Excitatory amino acid receptor antagonists
US4057560A (en) 1,2,2A,3,4,5 Hexahydrobenz[c,d]indol-1-yl-2-guanidines
EP0233413B1 (en) 3-(2-aminoethyl)indole and -indoline derivatives, processes for their preparation and pharmaceutical compositions containing them
HUT53867A (en) Process for producing new pyrrolidine derivatives and pharmaceutical compositions comprising such compounds
US3931222A (en) Tetrahydro-carbazole derivates
US3972994A (en) Disubstituted azabicycloalkanes
JPH09291076A (ja) 置換グアニジン誘導体およびその製法
EP0073645B1 (en) 2-cyclic amino-2-(1,2-benzisoxazol-3-yl)acetic acid ester derivatives, process for the preparation thereof and composition containing the same
US4315939A (en) Piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrole-2-carboxylic acid esters, pharmaceutical formulations containing these compounds and use in treating cardiac arrhythmias
US4808609A (en) Amino-(hydroxy)alkoxy-4-phenylpropyl indoles having antiarrythmic activity
US4048321A (en) Disubstituted azabicycloalkanes
CH657848A5 (de) 3,3-dialkyl- und 3,3-alkylen-indolinderivate, verfahren zu ihrer herstellung und pharmazeutische praeparate sie enthaltend.
WO1996026936A1 (fr) Nouveaux derives de piperazine amino-indole cycliques, leur procede de preparation et leur utilisation a titre de medicaments
JPH09508404A (ja) フェニルピロール誘導体およびそのドーパミンｄ▲下３▼アンタゴニストとしての使用

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SANDOZ AG